Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B virus Isolated from Belgian patients with different clinical manifestations

Journal of Medical Virology

Volumn 82, Issue 3, 2010, Pages 379-389

  Pourkarim, Mahmoud Reza ^a,b   Amini Bavil Olyaee, Samad ^c   Verbeeck, Jannick ^a   Lemey, Philippe ^a   Zeller, Mark ^a   Rahman, Mustafizur ^a   Maes, Piet ^a   Nevens, Frederik ^d   Van Ranst, Marc ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Belgium; Full length genome; Hepatitis B virus; Mutational pattern; Phylogenetic analysis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE;

AMINO ACID SUBSTITUTION; ARAB; ARTICLE; ASIAN; BELGIUM; CAUCASIAN; CLINICAL FEATURE; EUROPE; GENE DELETION; GENE INSERTION; GENE ISOLATION; GENE MUTATION; GENETIC CODE; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; NEGRO; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROMOTER REGION; PROTEIN DOMAIN; TURKEY (REPUBLIC); VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS RECOMBINANT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; BELGIUM; DNA, VIRAL; EUROPE; FEMALE; GENOME, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; PHYLOGENY; POINT MUTATION; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 75449117145     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21726     Document Type: Article

References (56)

1. Aiyar A. 2000. The use of CLUSTAL W and CLUSTAL X for multiple sequence alignment. Methods Mol Biol 132:221-241.
2. Amini-Bavil-Olyaee S, Herbers U, Mohebbi SR, Sabahi F, Zali MR, Luedde T, Trautwein C, Tacke F. 2009a. Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome. J Hepatol 51:647-654.
3. Amini-Bavil-Olyaee S, Herbers U, Sheldon J, Luedde T, Trautwein C, Tacke F. 2009b. The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains. Hepatology 49:1158-1165.
4. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Sabahi F, Abachi M, Azizi M, Mahboudi F. 2005. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol 76:318-326.
5. Amini-Bavil-Olyaee S, Trautwein C, Tacke F. 2007. Relevance of hepatitis B virus genome variability in organ transplantation. Hep Mon 7:35-41.
6. Amini-Bavil-Olyaee S, Vucur M, Luedde T, Trautwein C, Tacke F. 2009c. Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant Hepatitis B Virus e Antigen-positive and -negative strains. J Virol (in press) (DOI:101128/jvl.01796-09).
7. Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, Mizokami M, Chakravarty R. 2006. Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol 78:1164-1174.
8. Bartholomeusz A, Schaefer S. 2004. Hepatitis B virus genotypes: Comparison of genotyping methods. Rev Med Virol 14:3-16.
9. Carman WF. 1997. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4:11-20.
10. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. 2006. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153-1168.
11. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN. 2008. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: A case-control study. J Infect Dis 198:1634-1642.
12. Chen WN, Oon CJ. 2002. Hepatitis B virus mutants: An overview. J Gastroenterol Hepatol 17:S497-S499.
13. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60.
14. Cui C, Shi J, Hui L, Xi H, Zhuoma, Quni, Tsedan, Hu G. 2002. The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid. J Gen Virol 83:2773-2777.
15. DeMaddalena C, Giambelli C, Tanzi E, Colzani D, Schiavini M, Milazzo L, Bernini F, Ebranati E, Cargnel A, Bruno R, Galli M, Zehender G. 2007. High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus. Virology 365:113-124.
16. Di Lelio A, Cestari C, Lomazzi A, Beretta L. 1989. Cirrhosis: Diagnosis with sonographic study of the liver surface. Radiology 172:389-392.
17. Echevarria JM, Avellon A. 2006. Hepatitis B virus genetic diversity. J Med Virol 78:S36-42.
18. Echevarria JM, Avellon A, Magnius LO. 2005. Molecular epidemiology of hepatitis B virus in Spain: Identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol 76:176-184.
19. Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, Chang TT, Lei HY, Shiau AL, Su IJ. 2001. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33:277-286.
20. Georgi-Geisberger P, Berns H, Loncarevic IF, Yu ZY, Tang ZY, Zentgraf H, Schroder CH. 1992. Mutations on free and integrated hepatitis B virus DNA in a hepatocellular carcinoma: Footprints of homologous recombination. Oncology 49:386-395.
21. Hollinger FB. 2007. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 14:11-15.
22. Hsieh YH, Su IJ, Wang HC, Tsai JH, Huang YJ, Chang WW, Lai MD, Lei HY, Huang W. 2007. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1. Mol Cancer Res 5:1063-1072.
23. Kay A, Zoulim F. 2007. Hepatitis B virus genetic variability and evolution. Virus Res 127:164-176.
24. Koppelman MH, Zaaijer HL. 2004. Diversity and origin of hepatitis B virus in Dutch blood donors. J Med Virol 73:29-32.
25. Lai CL, Dienstag J, Schiff E, Leung NW, Atkins M, Hunt C, Brown N, Woessner M, Boehme R, Condreay L. 2003. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis 36:687-696.
26. Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, Jovanovic T. 2007. Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia. Arch Virol 152:2017-2025.
27. Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337:1733-1745.
28. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73:152-160.
29. Lorant V, Van Oyen H, Thomas I. 2008. Contextual factors and immigrants' health status: Double jeopardy. Health Place 14:678-692.
30. Meldal BH, Moula NM, Barnes IH, Boukef K, Allain JP. 2009. A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 90:1622-1628.
31. Micalessi MI, De Cock L, Vranckx R. 2005. Hepatitis B virus (HBV) genotyping in Belgian patients with chronic HBV infection. Clin Microbiol Infect 11:499-501.
32. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, Rostami Nejad M, Antikchi MH, Sabahi F, Zali MR. 2008. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect 14:858-866.
33. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
34. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, Levrero M, Raimondo G. 2007. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45:277-285.
35. Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, Campo S, Sagliocca L, Pasquali M, Tanzi E, Longo G, Raimondo G. 1997. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 26:495-499.
36. Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Maes P, Van Ranst M. 2010. Novel hepatitis B virus subgenotype A6 in African-Belgian patients. J Clin Virol 47:93-96.
37. Pourkarim MR, Verbeeck J, Rahman M, Amini-Bavil-Olyaee S, Forier AM, Lemey P, Maes P, Van Ranst M. 2009. Phylogenetic analysis of hepatitis B virus full-length genomes reveals evidence for a large nosocomial outbreak in Belgium. J Clin Virol 46:61-68.
38. Purdy MA, Talekar G, Swenson P, Araujo A, Fields H. 2007. A new algorithm for deduction of hepatitis B surface antigen subtype determinants from the amino acid sequence. Intervirology 50:45-51.
39. Rantala M, van de Laar MJ. 2008. Surveillance and epidemiology of hepatitis B and C in Europe - A review. Euro Surveill 22:1-8.
40. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
41. Schaefer S. 2007. Hepatitis B virus genotypes in Europe. Hepatol Res 37:S20-S26.
42. Seddigh-Tonekaboni S, Lim WL, Young B, Hou JL, Waters J, Luo KX, Thomas HC, Karayiannis P. 2001. Hepatitis B surface antigen variants in vaccines, blood donors and an interferon-treated patient. J Viral Hepat 8:154-158.
43. Sendi H, Mehrab-Mohseni M, Zali MR, Norder H, Magnius LO. 2005. T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D. J Gen Virol 86:2451-2458.
44. Sheldon J, Soriano V. 2008. Hepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother 61:766-768.
45. Szmaragd C, Foster GR, Manica A, Bartholomeusz A, Nichols RA, Balloux F. 2006. Genome-wide characterisation of hepatitis B mutations involved in clinical outcome. Heredity 97:389-397.
46. Tacke F, Manns MP, Trautwein C. 2004. Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance - Implications for novel antiviral strategies. Curr Med Chem 11:2667-2677.
47. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596-1599.
48. Tamura K, Nei M, Kumar S. 2004. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci USA 101:11030-11035.
49. Tanaka Y, Hasegawa I, Kato T, Orito E, Hirashima N, Acharya SK, Gish RG, Kramvis A, Kew MC, Yoshihara N, Shrestha SM, Khan M, Miyakawa Y, Mizokami M. 2004. A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 40:747-755.
50. Villeneuve JP. 2005. The natural history of chronic hepatitis B virus infection. J Clin Virol 34:S139-S142.
51. Wang Z, Hou J, Zeng G, Wen S, Tanaka Y, Cheng J, Kurbanov F, Wang L, Jiang J, Naoumov NV, Mizokami M, Qi Y. 2007. Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China. J Viral Hepat 14:426-434.
52. Wang Z, Liu Z, Zeng G, Wen S, Qi Y, Ma S, Naoumov NV, Hou J. 2005. A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China. J Gen Virol 86:985-990.
53. Weber B. 2006. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78:S59-S65.
54. Zaaijer HL, Torres P, Ontanon A, Ponte LG, Koppelman MH, Lelie PN, Hemert FJ, Boot HJ. 2008. Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection. J Med Virol 80:1344-1349.
55. Zharkikh A, Li WH. 1995. Estimation of confidence in phylogeny: The complete-and-partial bootstrap technique. Mol Phylogenet Evol 4:44-63.
56. Zollner B, Petersen J, Schroter M, Laufs R, Schoder V, Feucht HH. 2001. 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet 357:934-935.